SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-21-003641
Filing Date
2021-05-27
Accepted
2021-05-27 19:31:30
Documents
1
Period of Report
2020-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5723
  Complete submission text file 0001477932-21-003641.txt   7107
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Issuer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1620 BEACON STREET OXNARD CA 93033
Business Address
Goldin Anna (Reporting) CIK: 0001849223 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55908 | Film No.: 21975174